Mesirow Financial Investment Management, Inc. LCTX — LINEAGE CELL THERAPEUTICS IN

Ownership history in Mesirow Financial Investment Management, Inc.  ·  4 quarters on record

AI Ownership Summary

Mesirow Financial Investment Management, Inc. reported LINEAGE CELL THERAPEUTICS IN (LCTX) in 4 quarterly 13F filings from 2024 Q4 through 2026 Q2. The latest visible filing shows LCTX at 0.00% of the fund.

This page tracks quarterly shares, estimated market value, portfolio weight, filing dates, and disclosure-aligned stock prices directly from SEC EDGAR 13F filings.

What this LCTX ownership page tells you

This page is designed to answer the real investor question behind a 13F filing: how meaningful was Mesirow Financial Investment Management, Inc.'s position in LINEAGE CELL THERAPEUTICS IN, and how did that conviction change over time? You can read the holding window, peak weight, latest reported size, disclosure timing, and quarter-by-quarter changes without piecing the story together from raw SEC rows.

Freshest filing
Latest Reported Filing
2026 Q2

LCTX was reported at 0.00% of portfolio in the most recent visible filing.

High-water mark
Peak Conviction
0.0% in 2026 Q1

Peak weight helps separate a token disclosure from a real conviction holding the fund genuinely cared about.

Time in book
Holding Window
2024 Q4 to 2026 Q2

Longer holding windows often tell a very different story from short-lived tactical trades or one-quarter experiments.

Decision context
Why It Matters
Position size beats headlines

Knowing that a fund owned a stock is useful. Knowing whether it was a 0.20% placeholder or a true high-conviction position is where the signal actually starts.

LCTX stock page Mesirow Financial Investment Management, Inc. fund profile Mesirow Financial Investment Management, Inc. full holdings
How Mesirow Financial Investment Management, Inc. held LCTX — position size vs. price
% of Fund (quarterly)    LCTX price (quarter-end, indexed to 100)    SPY (indexed to 100)    QQQ (indexed to 100)
📋 Quarterly Holdings History 4 quarters  ▾
Quarter Action Sold % After 3M Timing Shares Change Chg % % of Fund Mkt Value Filed Price (Filed)
2026 Q2 REDUCED — — — 30,000 -500 -1.6% 0.00% $39K 2026-07-22 $1.11
2026 Q1 ADDED — — — 30,500 +10,500 +52.5% 0.00% $48K 2026-04-21 $1.64
2025 Q1 REDUCED — — — 20,000 -1 -0.0% 0.00% $9K 2025-05-08 $0.47
2024 Q4 INITIATED — — — 20,001 — — 0.00% $10K 2025-02-07 $0.67

🏢 Other funds also holding LCTX

As of 2026 Q3 — sorted by position size

Defender Capital, LLC. 3Y 7Y 1.99%

FAQ About Mesirow Financial Investment Management, Inc. and LCTX

These are the practical questions this page is built to answer before you even open the full history table.

How long has Mesirow Financial Investment Management, Inc. reported owning LCTX?

Mesirow Financial Investment Management, Inc. reported LCTX across 4 quarterly 13F filings, from 2024 Q4 through 2026 Q2.

What was the largest reported LCTX position in Mesirow Financial Investment Management, Inc.'s portfolio?

The largest reported portfolio weight for LCTX was 0.00% in 2026 Q1.

What is the latest reported LCTX position on this page?

The most recent filing on this page is 2026 Q2, when Mesirow Financial Investment Management, Inc. reported 30,000 shares, equal to 0.00% of portfolio, with an estimated market value of $39K.

What does the chart on this LCTX ownership page compare?

The chart compares Mesirow Financial Investment Management, Inc.'s quarterly LCTX portfolio weight with the stock's indexed share price, so you can see whether the fund was building, trimming, or holding the position as price moved.

How well did Mesirow Financial Investment Management, Inc. time their LCTX position?

Based on 13F filing dates vs. subsequent LCTX price moves, Mesirow Financial Investment Management, Inc. correctly timed 0 out of 3 reported position changes (0%). The annualised alpha on LCTX relative to SPY over the holding period was +370937.0%.

← Back to Mesirow Financial Investment Management, Inc. Holdings